Start Low, Go Slow: Why Jumping Straight to High-Dose Methylfolate Could Be Making You Worse

If you've recently been told you have MTHFR and discovered that methylfolate is the supplement you should be taking, you may be tempted to start at the highest dose you can find — 5mg, 10mg, even 15mg. More is better, right? Not with methylfolate.

For a significant proportion of people — particularly those with COMT slow variants, MAO-A slow variants, or depleted B12 — jumping straight to high-dose methylfolate can produce a paradoxical worsening of the very symptoms you're trying to address. This is known as the methylfolate start reaction, or overmethylation.

What Is Overmethylation?

Overmethylation occurs when methylation support is introduced too rapidly, flooding the methylation cycle with methyl groups faster than the downstream pathways can handle them. The result is excess SAM production, followed by a cascade of neurotransmitter-related effects: anxiety, irritability, insomnia, racing thoughts, palpitations, and a general sense of neurological agitation.

For slow COMT individuals, this is particularly problematic. COMT is responsible for clearing dopamine and noradrenaline in the prefrontal cortex. When SAM — its methyl donor — surges, COMT activity increases, initially producing a state of catecholamine excess before the system rebalances. The interim period can be distinctly unpleasant.

The Start Low, Go Slow Protocol

The evidence-based approach to starting methylfolate is to begin at the lowest available dose — typically 100-200mcg — and hold that dose for two to four weeks before increasing. This allows the methylation cycle to adjust gradually, supporting downstream pathways before the supply of methyl groups increases further. If any worsening of symptoms occurs at a given dose, hold at that level until symptoms stabilise before proceeding.

Ensuring adequate B12 before starting methylfolate is also important. Methylfolate drives homocysteine into the remethylation pathway — a reaction that requires methylcobalamin B12 as a cofactor. Without sufficient B12, this pathway can become rate-limited, producing a paradoxical rise in homocysteine despite methylfolate supplementation.

When to Seek Guidance

If you experience significant worsening of symptoms when starting methylfolate, or if you are on medications affecting neurotransmitter levels (particularly SSRIs, SNRIs, or MAO inhibitors), work with a healthcare practitioner familiar with methylation before proceeding. The interaction between methylfolate and serotonergic medications requires careful management.

NeuroThrive™ products are food supplements and are not intended to diagnose, treat, or cure any medical condition. Always consult your GP before beginning any new supplement programme, particularly if you are on prescription medications.